N.E.W. Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
N
MG
N.E.W. Advisory Services's NVO Position: Q2 2026 in Review
N.E.W. Advisory Services reduced its Novo Nordisk (NVO) stake by 25% in Q2 2026, selling an estimated $22.7K and leaving 1,586 shares worth $76K. The position accounts for 0.01% of the portfolio, ranked #318.
N.E.W. Advisory Services first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $139K in Q2 2025. 959 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- N.E.W. Advisory Services held 1,586 shares of Novo Nordisk worth $76K as of Q2 2026.
- N.E.W. Advisory Services sold 528 Novo Nordisk shares in Q2 2026, an estimated $22.7K.
- Novo Nordisk made up 0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #318 holding.
- N.E.W. Advisory Services first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
- N.E.W. Advisory Services's Novo Nordisk position peaked at $139K in Q2 2025.
- 959 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.